Full video transcriptClick to expand
Auto-generated transcript of @tru.md's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Ranking different forms of NAD from 1 to 10.
- 0:02IV therapy is at 10.
- 0:04Love it.
- 0:05The downside is that you've got to sit there for a little bit,
- 0:07but the best form to get the most NAD.
- 0:09Injections are also great.
- 0:11I'll give it a 9 because you're not getting as high of those.
- 0:14NAD face creams.
- 0:15So I think this is supposed to be for the quality of your skin
- 0:19and not really for longevity.
- 0:21So I'll give it a 1 out of 10.
- 0:22NAD3 is a supplement.
- 0:23It doesn't have any actual NAD in it,
- 0:25but it helps you make and release more of your own NAD.
- 0:28I love this product.
- 0:30I'll give it an 8.
- 0:31Straight NAD supplements, meaning actual NAD in an oral supplement,
- 0:35I do not like your body doesn't absorb it.
- 0:38There are some new ones out there that say they're like a liposomal form.
- 0:42I think the jury's still out on those specifically,
- 0:44but in general, NAD supplements, I give them a 0.
- 0:48NAD precursors.
- 0:49We're talking about an R nicotinamide riboside,
- 0:51an NMN nicotinamide mono nucleotide.
- 0:54You know, I used to think this was the best thing ever,
- 0:56and I've kind of fallen off that path.
- 0:59I do think it has some utility,
- 1:01but there are potentially some side effects
- 1:04and some kind of mystery still around them.
- 1:06So I'll give them a 5.
- 1:07Two quick things here.
- 1:08First, make sure that if you're starting one of these different types of NAD,
- 1:12that you have a doctor that you can talk to and ask these questions.
- 1:16First, if you're thinking about starting one of these forms of NAD,
- 1:18make sure you find yourself a doctor that can speak to these.
- 1:21Someone who's tried them, that prescribes them,
- 1:23and can talk to you by the different forms of therapy.
- 1:26And next, if you just have a question about NAD that you want to ask real quick,
- 1:29leave it in the comment below.
NAD IV therapy ranked 'gold standard': does the science agree?
Quick answer
The creator ranks NAD+ delivery methods based on assumed bioavailability, placing IV infusion above oral precursors like NMN and NR, despite the fact that NMN and NR have more published human pharmacokinetic and safety trial data than IV NAD+ therapy does. Oral NAD+ itself does have poor bioavailability, but precursors reliably raise systemic NAD+ levels in peer-reviewed trials, making a score of 5 out of 10 for that category inconsistent with the evidence. The recommendation to consult a prescribing physician before starting any form of NAD therapy is clinically appropriate and the strongest part of the video.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
NAD+ Peptide Complex access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For NAD IV therapy ranked 'gold standard': does the science agree?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
NAD+ Peptide Complex is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this nad+ video claims cluster
Best for searchers separating NAD+ longevity marketing from practical metabolic and safety questions.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "NAD IV therapy ranked 'gold standard': does the science agree?" from Dr. Michael Setareh. We read the clip as a Peptide social video fact-checks claim about NAD+ Peptide Complex, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator ranks NAD+ delivery methods based on assumed bioavailability, placing IV infusion above oral precursors like NMN and NR, despite the fact that NMN and NR have more published human pharmacokinetic and safety trial data than IV NAD+ therapy does.
The reason this review is not generic is the source wording and the canonical claim label "peptides watch me rank nad treatments from 1 to 10 1 nad iv therapy t." In this clip, the useful excerpt is: "Ranking different forms of NAD from 1 to 10." That wording changes the review because it points to NAD+ Peptide Complex safety, access, evidence, and fit, not a one-size-fits-all protocol.
The source trail for this page is checked against The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging (2015), Effects of glycyl-histidyl-lysine-Cu on wound healing (Search), and Copper peptide and skin remodeling literature (Search), plus the creator's own wording. NAD+ Peptide Complex still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator ranks NAD+ delivery methods based on assumed bioavailability, placing IV infusion above oral precursors like NMN and NR, despite the fact that NMN and NR have more published human pharmacokinetic and safety trial data than IV NAD+ therapy does.
FormBlends verdict
NAD+ Peptide Complex safety, access, evidence, and fit
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with the NAD+ Peptide Complex guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator ranks NAD+ delivery methods based on assumed bioavailability, placing IV infusion above oral precursors like NMN and NR, despite the fact that NMN and NR have more published human pharmacokinetic and safety trial data than IV NAD+ therapy does. Oral NAD+ itself does have poor bioavailability, but precursors reliably raise systemic NAD+ levels in peer-reviewed trials, making a score of 5 out of 10 for that category inconsistent with the evidence. The recommendation to consult a prescribing physician before starting any form of NAD therapy is clinically appropriate and the strongest part of the video.
- NMN and NR have more published human pharmacokinetic safety data than IV NAD+ therapy does for longevity indications, making a ranking of 5 vs. 10 inconsistent with the evidence base.
- A 2017 PLOS ONE trial by Airhart et al. showed oral NR raised whole-blood NAD+ by up to 2.7-fold, directly contradicting the implication that precursors barely work.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- NAD+ Peptide Complex decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the NAD+ Peptide Complex guide, cost path, safety notes, and provider review before acting.
Review NAD+ Peptide ComplexWhat You'll Learn
- NMN and NR have more published human pharmacokinetic safety data than IV NAD+ therapy does for longevity indications, making a ranking of 5 vs. 10 inconsistent with the evidence base.
- A 2017 PLOS ONE trial by Airhart et al. showed oral NR raised whole-blood NAD+ by up to 2.7-fold, directly contradicting the implication that precursors barely work.
- IV NAD+ does achieve higher acute plasma concentrations, but plasma concentration is not a validated surrogate for longevity or energy outcomes in healthy adults.
- Oral NAD+ as a free molecule does have poor gut bioavailability. The creator's 0 rating for standard oral NAD is defensible, though liposomal skepticism should be labeled as a data gap rather than a verdict.
- NAD3 is a proprietary blend with very limited independent human trial data. Scoring it higher than NMN or NR is not supported by comparative published evidence.
- Anyone with a history of cancer should consult an oncologist before taking NAD precursors, due to unresolved research questions around NAD metabolism and tumor cell proliferation.
- IV NAD+ therapy is not FDA-approved for any anti-aging indication and is typically administered as a compounded, off-label treatment at significant out-of-pocket cost.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @tru.md actually say?
The creator ranked NAD delivery methods on a 1-10 scale, putting IV therapy at 10, injections at 9, and oral NAD supplements at 0. They gave NMN and NR precursors a lukewarm 5, citing "potentially some side effects and some kind of mystery still around them." They also praised NAD3 as a supplement that "helps you make and release more of your own NAD" and scored it an 8. The creator appropriately ended by telling viewers to find a doctor before starting any of these.
To their credit, they did not promise cures or specific outcomes. The rankings are presented as personal clinical opinion, not absolute science. But clinical opinion without citing evidence is still just opinion, and on a platform like TikTok, it travels like fact.
Does the science back this up?
Partially, and the parts that don't are worth paying attention to. IV NAD+ does achieve higher plasma concentrations than oral routes, but "maximum absorption" does not automatically translate to superior clinical outcomes in healthy people. The evidence base for IV NAD+ in longevity specifically is thin.
A 2023 review by Mehmel et al. in Nutrients confirmed that oral NR and NMN do raise blood NAD+ levels in humans, which directly contradicts the creator's implication that precursors barely work. The effect size varies, but calling them a 5 out of 10 while rating unproven IV therapy a 10 is not a scientifically balanced comparison. On oral NAD supplements specifically, the creator is on firmer ground. NAD+ as a molecule has poor oral bioavailability, and the liposomal claim remains largely unvalidated in peer-reviewed literature as of 2024.
- Mehmel M, Jovanovic N, Spitz U (2021, Nutrients): NR and NMN supplementation raises systemic NAD+ in multiple human trials.
- Airhart SE et al. (2017, PLOS ONE): Oral NR raised whole-blood NAD+ by up to 2.7-fold in a small human trial.
What did they get wrong (or right)?
The biggest problem is the IV-at-10 framing. There are no randomized controlled trials demonstrating that IV NAD+ outperforms oral precursors for longevity or energy in otherwise healthy adults. The creator leans on absorption logic, which is reasonable pharmacokinetically, but absorption is not the same as efficacy. Giving IV therapy a 10 without that caveat overstates the evidence.
They got the oral NAD+ critique mostly right. The molecule is degraded before meaningful systemic absorption in most formulations. The liposomal skepticism is also defensible given the lack of published human pharmacokinetic data for those products specifically.
The precursor downgrade is where this gets frustrating. Saying NMN and NR have "mystery still around them" without explaining what that means leaves viewers with vague anxiety about a category with more human trial data than IV NAD+ has. The side effect concern likely references Guarente lab discussions around CD38 or mTOR crosstalk, but that context was absent here.
What should you actually know?
NAD+ declines with age. That part is not disputed. What is disputed is which delivery method most efficiently raises tissue-level NAD+ in ways that matter clinically, and whether raising it at all extends healthy human lifespan. Those are different questions, and conflating them is how wellness marketing works.
IV NAD+ therapy is not FDA-approved for any longevity indication. It is used off-label, often compounded, and sessions can cost hundreds of dollars. NMN and NR have more published human safety and pharmacokinetic data than IV NAD+ does at this point. That does not make precursors definitively better, but it does mean ranking them a 5 while IV gets a 10 inverts the evidence hierarchy.
The creator's advice to consult a physician before starting is correct and worth repeating. NAD precursors interact with medications metabolized through sirtuin pathways, and anyone with a history of cancer should have a specific conversation with their oncologist before supplementing, given unresolved questions around NAD and tumor cell metabolism.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Dr. Michael Setareh · TikTok creator
1.5K views on this video
Watch me rank NAD treatments from 1 to 10: 1️⃣ NAD IV Therapy – The gold standard. Direct infusion for maximum absorption, energy, and anti-aging benefits. 2️⃣ NAD Injections – A quick boost that bypasses digestion for efficient results between IV sessions. 3️⃣ NAD+ Face Cream – Targets skin directly to reduce fine lines and wrinkles while supporting skin health. 4️⃣ NAD3 Supplements – A next-gen formula that supports cellular repair and boosts NAD levels without containing NAD itself. 5️⃣ Stra
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about nmn?
NMN and NR have more published human pharmacokinetic safety data than IV NAD+ therapy does for longevity indications, making a ranking of 5 vs. 10 inconsistent with the evidence base.
What does the video say about a 2017 plos one trial by airhart et al. showed?
A 2017 PLOS ONE trial by Airhart et al. showed oral NR raised whole-blood NAD+ by up to 2.7-fold, directly contradicting the implication that precursors barely work.
What does the video say about iv nad+ does achieve higher acute plasma concentrations,?
IV NAD+ does achieve higher acute plasma concentrations, but plasma concentration is not a validated surrogate for longevity or energy outcomes in healthy adults.
What does the video say about oral nad+ as a free molecule does have poor gut?
Oral NAD+ as a free molecule does have poor gut bioavailability. The creator's 0 rating for standard oral NAD is defensible, though liposomal skepticism should be labeled as a data gap rather than a verdict.
What does the video say about nad3?
NAD3 is a proprietary blend with very limited independent human trial data. Scoring it higher than NMN or NR is not supported by comparative published evidence.
What does the video say about anyone with a history of cancer should consult an oncologist?
Anyone with a history of cancer should consult an oncologist before taking NAD precursors, due to unresolved research questions around NAD metabolism and tumor cell proliferation.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Dr. Michael Setareh, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.